Gland Pharma Limited (GLAND) — Cash Flow Quality Index
Gland Pharma Limited (GLAND) has a Cash Flow Quality Index of 1.49x as of September 2025. Operating cash flow of Rs5.93 Billion exceeds net income of Rs3.99 Billion, indicating high earnings quality where cash backs reported profits. Also explore balance sheet size of Gland Pharma Limited for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Gland Pharma Limited Cash Flow Quality Index (2017–2025)
Historical Cash Flow Quality Index for Gland Pharma Limited across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check GLAND goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Gland Pharma Limited (2017–2025)
Year-by-year earnings quality comparison for Gland Pharma Limited. For live market cap and the full company financial profile, see Gland Pharma Limited stock valuation.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.31x | Rs9.15 Billion | Rs6.99 Billion | ▲ +1.5% |
| 2024 | 1.29x | Rs9.97 Billion | Rs7.72 Billion | ▲ +273.9% |
| 2023 | 0.35x | Rs3.64 Billion | Rs10.55 Billion | ▼ -29.4% |
| 2022 | 0.49x | Rs7.91 Billion | Rs16.19 Billion | ▲ +7.8% |
| 2021 | 0.45x | Rs6.05 Billion | Rs13.35 Billion | ▼ -35.8% |
| 2020 | 0.71x | Rs7.01 Billion | Rs9.93 Billion | ▲ +161.5% |
| 2019 | 0.27x | Rs1.85 Billion | Rs6.86 Billion | ▼ -33.0% |
| 2018 | 0.40x | Rs2.02 Billion | Rs5.01 Billion | ▼ -65.0% |
| 2017 | 1.15x | Rs4.76 Billion | Rs4.14 Billion | — |